119 related articles for article (PubMed ID: 38863318)
21. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors.
Xue Z; Tang S; Ou J; Fang Y; Qiu M; Hong K; Tian X; Zhang H; Liu C; Ma L; Zhang S
World J Urol; 2024 May; 42(1):364. PubMed ID: 38819448
[TBL] [Abstract][Full Text] [Related]
22. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
23. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
[TBL] [Abstract][Full Text] [Related]
24. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
26. Validation of the World Health Organization/International Society of Urological Pathology grading for Chinese patients with clear cell renal cell carcinoma.
Xiao Q; Yi X; Guan X; Yin H; Wang C; Zhang L; Pang Y; Li M; Gong G; Chen D; Liu L
Transl Androl Urol; 2020 Dec; 9(6):2665-2674. PubMed ID: 33457238
[TBL] [Abstract][Full Text] [Related]
27. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
28. External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population.
Lee HJ; Lee A; Huang HH; Lau WKO
Urol Oncol; 2019 Jun; 37(6):356.e9-356.e18. PubMed ID: 30905510
[TBL] [Abstract][Full Text] [Related]
29. Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study.
Almdalal T; Sundqvist P; Harmenberg U; Hellström M; Lindskog M; Lindblad P; Lundstam S; Ljungberg B
Eur Urol Open Sci; 2022 May; 39():22-28. PubMed ID: 35528783
[TBL] [Abstract][Full Text] [Related]
30. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.
Zhao F; Liu X; Zhang C; Zhu H; Qi N
Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976
[No Abstract] [Full Text] [Related]
31. Prognostic role of the endothelial cell-specific molecule-1 histopathologic expression in renal cell cancer.
Bocu K; Batur AF; Celik ZE; Gül M; Altıntas E; Kaynar M; Kılıç O; Akand M; Tataroglu SN; Goktas S
Urol Oncol; 2023 Jun; 41(6):297.e1-297.e9. PubMed ID: 37127479
[TBL] [Abstract][Full Text] [Related]
32. Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis.
Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Urol Oncol; 2020 May; 38(5):506-514. PubMed ID: 32139292
[TBL] [Abstract][Full Text] [Related]
33. Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma.
Blackmur JP; Gaba F; Fernando D; Williams S; O'Donnell M; McNeill A; Stewart GD; Leung S; Laird A
Urol Oncol; 2021 Jul; 39(7):438.e11-438.e21. PubMed ID: 34023196
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between metabolic syndrome and prognosis of patients with clear cell renal cell carcinoma].
Zuo MN; DU YQ; Yu LP; Dai X; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):636-643. PubMed ID: 35950385
[TBL] [Abstract][Full Text] [Related]
35. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
36. Expression and clinical value of SALL4 in renal cell carcinomas.
Che J; Wu P; Wang G; Yao X; Zheng J; Guo C
Mol Med Rep; 2020 Aug; 22(2):819-827. PubMed ID: 32468053
[TBL] [Abstract][Full Text] [Related]
37. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
[TBL] [Abstract][Full Text] [Related]
38. Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma - results from the National Swedish Kidney Cancer Register.
Almdalal T; Karlsson Rosenblad A; Hellström M; Kjellman A; Lindblad P; Lundstam S; Sundqvist P; Ljungberg B
Scand J Urol; 2023; 57(1-6):67-74. PubMed ID: 36520023
[TBL] [Abstract][Full Text] [Related]
39. Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries.
Marquardt A; Solimando AG; Kerscher A; Bittrich M; Kalogirou C; Kübler H; Rosenwald A; Bargou R; Kollmannsberger P; Schilling B; Meierjohann S; Krebs M
Front Oncol; 2021; 11():621278. PubMed ID: 33791209
[No Abstract] [Full Text] [Related]
40. Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas.
Qu JY; Jiang H; Wang XF; Song XH; Hao CJ
Diagn Interv Radiol; 2022 Nov; 28(6):555-562. PubMed ID: 36550755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
